The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

There is a real art to writing a CV so it shows the reader how suitable you are for the job you’re applying for, says Matthew ...

The practice inflated costs for consumers and insurers on key treatments for cancer, multiple sclerosis, HIV, organ transplants, and other conditions and procedures, the FTC said. The report ...

Pharmacies like Snyders rely on reimbursements to make ends meet. When his business dispenses prescriptions, the repayment ...

Melissa Rivers recalls how quickly the Los Angeles wildfires spread, leaving her little time to gather cherished belongings ...

The passenger vehicle (PV) segment in India, comprising cars, utility vehicles (UVs), and vans, posted a 4.2 per cent growth ...

CVS and its top executives succeeded Tuesday in convincing Rhode Island’s top court to affirm the dismissal of allegations ...

Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of creating pharmacy deserts by steering consumers to their own pharmacies and ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

Health-care companies slid after a profit warning from Eli Lilly. Shares of the obesity-drug maker tumbled after it slashed its projection for fourth-quarter revenue as the market for drugs that ...

A report from the Federal Trade Commission (FTC) has determined that pharmacy benefit managers (PBMs) are linked to significant cost increases for cancer, HIV, and other critical specialty drugs.